Literature DB >> 2817838

The early risk of multiple sclerosis following isolated acute syndromes of the brainstem and spinal cord.

D H Miller1, I E Ormerod, P Rudge, B E Kendall, I F Moseley, W I McDonald.   

Abstract

A combined clinical and magnetic resonance imaging follow-up study was undertaken to determine the risk of early progression to multiple sclerosis in patients who present with clinically isolated lesions of the brainstem or spinal cord. Progression to multiple sclerosis was seen in 13 patients (57%) who had a brainstem syndrome and in 14 patients (42%) who had a spinal cord syndrome after mean intervals of 15 and 16 months, respectively. The risk of progression was increased by the presence of oligoclonal bands in the cerebrospinal fluid of patients with either syndrome and by the presence of disseminated brain lesions, as detected by magnetic resonance imaging, in those with a spinal cord syndrome. Follow-up revealed evidence of multiphasic disease in 24 (69%) of 35 patients who had disseminated lesions on magnetic resonance imaging scans at presentation, suggesting that multiple sclerosis is the usual cause of such lesions.

Entities:  

Mesh:

Year:  1989        PMID: 2817838     DOI: 10.1002/ana.410260508

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  26 in total

1.  Isolated demyelinating syndromes: comparison of different MR imaging criteria to predict conversion to clinically definite multiple sclerosis.

Authors:  M Tintoré; A Rovira; M J Martínez; J Rio; P Díaz-Villoslada; L Brieva; C Borrás; E Grivé; J Capellades; X Montalban
Journal:  AJNR Am J Neuroradiol       Date:  2000-04       Impact factor: 3.825

2.  Multiple sclerosis and the mind.

Authors:  M A Ron; A Feinstein
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-01       Impact factor: 10.154

3.  Treatment with methylprednisolone in relapses of multiple sclerosis patients: immunological evidence of immediate and short-term but not long-lasting effects.

Authors:  E M Martínez-Cáceres; M A Barrau; L Brieva; C Espejo; N Barberà; X Montalban
Journal:  Clin Exp Immunol       Date:  2002-01       Impact factor: 4.330

4.  Magnetization transfer histogram analysis of monosymptomatic episodes of neurologic dysfunction: preliminary findings.

Authors:  J S Kaiser; R I Grossman; M Polansky; J K Udupa; Y Miki; S L Galetta
Journal:  AJNR Am J Neuroradiol       Date:  2000 Jun-Jul       Impact factor: 3.825

5.  Prognostic value of MR and magnetization transfer imaging findings in patients with clinically isolated syndromes suggestive of multiple sclerosis at presentation.

Authors:  G Iannucci; C Tortorella; M Rovaris; M P Sormani; G Comi; M Filippi
Journal:  AJNR Am J Neuroradiol       Date:  2000 Jun-Jul       Impact factor: 3.825

6.  A prospective study on the predictive value of CSF oligoclonal bands and MRI in acute isolated neurological syndromes for subsequent progression to multiple sclerosis.

Authors:  E Paolino; E Fainardi; P Ruppi; M R Tola; V Govoni; I Casetta; V C Monetti; E Granieri; M Carreras
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-05       Impact factor: 10.154

Review 7.  Cerebrospinal fluid.

Authors:  E J Thompson
Journal:  J Neurol Neurosurg Psychiatry       Date:  1995-10       Impact factor: 10.154

8.  A study of oligoclonal band negative multiple sclerosis.

Authors:  A Z Zeman; D Kidd; B N McLean; M A Kelly; D A Francis; D H Miller; B E Kendall; P Rudge; E J Thompson; W I McDonald
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-01       Impact factor: 10.154

9.  Sensitivities and predictive values of paraclinical tests for diagnosing multiple sclerosis.

Authors:  G Filippini; G C Comi; V Cosi; L Bevilacqua; M Ferrarini; V Martinelli; R Bergamaschi; M Filippi; A Citterio; L D'Incerti
Journal:  J Neurol       Date:  1994-01       Impact factor: 4.849

10.  A three-year, multi-parametric MRI study in patients at presentation with CIS.

Authors:  Maria A Rocca; Federica Agosta; Maria P Sormani; Kryshani Fernando; Mar Tintorè; Tijmen Korteweg; Paola Tortorella; David H Miller; Alan Thompson; Alex Rovira; Xavier Montalban; Chris Polman; Frederik Barkhof; Massimo Filippi
Journal:  J Neurol       Date:  2008-02-18       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.